Synthesis, characterization, DFT calculations and biological activity of derivatives of 3-acetylpyridine and the zinc(II) complex with the condensation product of 3-acetylpyridine and semicarbazide by Čobeljić, Božidar et al.
Accepted Manuscript
Synthesis, characterization, DFT calculations and biological activity of deriva‐
tives of 3-acetylpyridine and the zinc(II) complex with the condensation product
of 3-acetylpyridine and semicarbazide
Božidar Čobeljić, Andrej Pevec, Iztok Turel, Marcel Swart, Dragana Mitić,
Marina Milenković, Ivanka Marković, Maja Jovanović, Dušan Sladić, Marko
Jeremić, Katarina Anđelković
PII: S0020-1693(13)00207-7
DOI: http://dx.doi.org/10.1016/j.ica.2013.04.017
Reference: ICA 15422
To appear in: Inorganica Chimica Acta
Received Date: 5 February 2013
Revised Date: 10 April 2013
Accepted Date: 11 April 2013
Please cite this article as: B. Čobeljić, A. Pevec, I. Turel, M. Swart, D. Mitić, M. Milenković, I. Marković, M.
Jovanović, D. Sladić, M. Jeremić, K. Anđelković, Synthesis, characterization, DFT calculations and biological
activity of derivatives of 3-acetylpyridine and the zinc(II) complex with the condensation product of 3-acetylpyridine
and semicarbazide, Inorganica Chimica Acta (2013), doi: http://dx.doi.org/10.1016/j.ica.2013.04.017
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
1 
 
Synthesis, characterization, DFT calculations and biological activity of derivatives of  
3-acetylpyridine and the zinc(II) complex with the condensation product of  
3-acetylpyridine and semicarbazide 
 
Božidar Čobeljića, Andrej Pevecb, Iztok Turelb, Marcel Swartc,d, Dragana Mitića, Marina 
Milenkoviće, Ivanka Markovićf, Maja Jovanovićf, Dušan Sladića, Marko Jeremića, Katarina 
Anđelković*a 
 
a
 Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia 
b
 Faculty of Chemistry and Chemical Technology, University of Ljubljana, Aškerčeva 5, 1000 
Ljubljana, Slovenia 
c
 Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, 08010 
Barcelona, Spain 
d
 Institut de Química Computacional and Departament de Química, Universitat de Girona, 
Campus Montilivi, 17071 Girona, Spain 
e
 Department of Microbiology and Immunology, Faculty of Pharmacy, University of 
Belgrade, Vojvode Stepe 450, Serbia 
f
 Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 
Pasterova 2, 11000 Belgrade, Serbia 
 
 
 
Keywords: Zn(II) complex, Schiff base, DFT calculations, biological activity 
 
Abstract 
 
A Schiff base of 3-acetylpyridine with semicarbazide as well as the corresponding 
tetrahedral Zn(II) complex were synthesized and characterized by X-ray crystal structure 
analysis and spectroscopic methods. It is interesting to note that the ligand coordinated as a 
monodentate although there are several donor atoms in it. Computational studies showed that 
such structure is more stable than the hypothetical structure with one ligand bound as a 
bidentate. The complex exibited moderate antibacterial, antifungal and cytotoxic activities 
while the ligand was mostly inactive. The complex strongly induced formation of reactive 
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oxygen species in tumor cell lines. It also influenced cell cycle progression in tumor cell lines, 
and induced autophagy. The latter effect is, at least in part, a protective one. 
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1. Introduction 
 
Condensation derivatives of 2-acetylpyridine with hydrazines, hydrazides and 
dihydrazides and their transition metal compexes have been extensively studied by our group 
[1–3]. These ligands have a large number of possible donor atoms and therefore display a 
diverse behavior in metal coordination. The central metal atom and the nature of the ligand 
determine the way of coordination.  
There is a small number of papers concerning derivates of 3-acetylpyridine and their 
complexes in none of which biological activity was studied [4–8]. Bis hydrazone of hydrazine 
and 3-acetylpyridine was coordinated to Zn(II) via pyridine nitrogen and not via hydrazone 
nitrogen [4]. 
In the complexes of Pt(II), Co(II), Ni(II) and Cu(I) with condensation derivative of  
3-acetylpyridine and thiosemicarbazide the ligand is coordinated as a bidentate via thione 
sulfur and azomethine nitrogen while the heteroaromatic nitrogen is not involved in 
coordination [5–7]. 
There is only one publication concerning complexes of the condensation derivative of  
3-acetylpyridine with semicarbazide. Based on similarity of spectral properties of 
oxovanadium(IV) complexes with 3-acetylpyridine semicarbazone and 2-acetylpyridine 
semicarbazone and X-ray structure of the latter complex, it was assumed that the  
3-acetylpyridine derivative was coordinated as a monodentate in neutral form via the carbonyl 
oxygen of the side chain [8]. 
Zinc is considered the most abundant trace intracellular element and a substantial amount 
of this element is incorporated in the nucleus [9]. As some other metal ions zinc has many 
positive physiological effects but changes in its metabolism or trafficking may be related to 
some diseases [10,11]. 
Zinc(II) ions are present in zinc finger proteins that recognize and bind to DNA [12,13]. 
In zinc fingers the zinc ion is usually tetrahedrally coordinated by cysteine and histidine 
residues [14]. Lippert has stressed that the role of zinc in nucleic acid chemistry is unique in 
many aspects [15]. For example, from all metal ions only zinc(II) ions are able to facilitate the 
rewinding of molten DNA [15]. 
In the present paper condensation products of 3-acetylpyridine with different hydrazide 
type compounds were studied for their coordination behavior and antitumor and antimicrobial 
activities. The present work describes synthesis, characterization and biological activity of 
derivatives of 3-acetylpyridine with semicarbazide, oxamic hydrazide, ethyl carbazate and 
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zinc(II) complex with 3-acetylpyridine semicarbazone. Coordination behaviour of the ligands 
was investigated by DFT calculations. 
 
2. Experimental 
 
2.1. Materials and methods 
 
All solvents (reagent grade) were obtained from commercial suppliers and used without 
further purification. The elemental analyses (C, H, N) were performed by the standard 
micromethods using the ELEMENTAR Vario ELIII C,H,N analyser. IR spectra were 
recorded on Perkin-Elmer FT-IR 1725X spectrophotometer by the KBr technique in the 
region 4000–400 cm-1. Abbreviations used for IR spectra: vs, very strong; s, strong; m, 
medium; w, weak. NMR spectral assignments and structural parameters were obtained by 
combined use of 1H homonuclear spectroscopy (2D NOESY) and multinuclear proton-
detected spectroscopy (2D HSQC, 2D HMBC). The NMR spectra were performed on Bruker 
Avance 500 equipped with broad-band direct probe. All spectra were measured at 298 K. 2D 
NOESY spectra were collected with 4 scans per t1-increment and mixing time of 1 s. 
Chemical shifts are given on δ scale relative to tetramethylsilane (TMS) as internal standard 
for 1H and 13C. Abbreviations used for NMR spectra: s, singlet; d, doublet; dd, doublet of 
doublets; t, triplet; q, quartet; m, multiplet. All microorganism tests were performed in Műller 
Hinton broth for the bacterial strains and in Sabouraud dextrose broth for the yeast. Human 
promyelocytic leukemia (HL-60), human glioma (U251), rat glioma (C6), mouse 
fibrosarcoma (L929) and mouse melanoma (B16) cell lines were obtained from the European 
Collection of Animal Cell Cultures (Salisbury, UK). Flow cytometry analysis was performed 
on a FACSCalibur flow cytometer (BD Biosciences, Heidelberg, Germany), using CellQuest 
Pro software for acquisition and analysis. All statistical data were analyzed by t-test or 
ANOVA followed by Student-Newman-Keuls test. Statistical significance of the differences 
of means was analyzed at the significance level of p < 0.05. 
 
2.2. Synthesis of (2E)-2-[1-(pyridin-3-yl)ethylidene]hydrazinecarboxamide hydrochloride 
dihydrate (HL1, C8H15ClN4O3) 
 
3-Acetylpyridine (0.11 cm-3, 1 mmol) was added to a solution of semicarbazide 
hydrochloride (111 mg, 1 mmol) in water (25 cm-3) and the mixture was refluxed for 3 h. 
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After 7 days colorless crystals were obtained (180 mg, 72%), mp 214–230 ºC. Anal. Calc. for 
C8H15ClN4O3: C, 38.33; H, 6.03; N, 22.35. Found: C, 38.53; H, 6.08; N, 22.49 %. 1H NMR 
(500 MHz; DMSO-d6; Me4Si): δ = 9.84 (s, 1 H, N(3)H), 9.39 (d, 1 H, 4J = 1.7, H-1), 8.96 (m, 
1 H, 3J = 8.9, 4J = 1.8, H-5), 8.81 (dd, 1 H, 3J = 6.3, 4J = 0.8, H-3), 8.02 (dd, 1 H, 3J = 8.2, 4J 
= 2.8, H-4), 6.75 (s, 2 H, N(4)H2), 2.26 (s, 3 H, C(7)H3) ppm; 13C NMR (125 MHz, DMSO-
d6; Me4Si): δ = 156.90 (C-8), 141.72 (C-5), 140.32 (C-1), 139.43 (C-6), 138.73 (C-3), 137.28 
(C-2), 126.64 (C-4), 12.92 (C-7) ppm. IR (KBr; ν/cm-1):  = 3424vs, 3289vs, 2358w, 
2167w, 1691s, 1573m, 1533m, 1455m, 1411m, 1313w, 1247w, 1157m, 1088w, 892w, 668m. 
  
2.3. Synthesis of 2’-[1-(3-pyridinyl)ethylidene]oxamohydrazide (HL2, C9H10N4O2) 
 
To a solution of oxamic hydrazide (103 mg, 1 mmol) in water (25 cm-3) 3-acetylpyridine 
(0.11 cm-3, 1 mmol) was added and the mixture was refluxed for 3 h. After 4–5 days colorless 
crystals were obtained (130 mg, 65%), m.p.: 240 ºC. Anal. Calc. for C9H10N4O2: C, 52.42; H, 
4.89; N, 27.17. Found: C, 52.17; H, 4.86; N, 26.92 %.. 1H NMR (500 MHz; DMSO-d6; 
Me4Si): δ = 10.88 (s, 1 H, N(3)H), 9.00 (d, 1 H, 4J = 2.0, H-1), 8.65 (m, 1 H, 3J = 6.0, 4J = 
1.5, H-5), 8.35 (s, 1 H, N(4)H2), 8.22 (dd, 1 H, 3J = 7.5, 4J = 1.5, H-3), 8.05 (s, 1 H, N(4)H2), 
7.50 (dd, 1 H, 3J = 5.5, 5J = 3.0, H-4), 2.36 (s, 3 H, C(7)H3) ppm. 13C NMR (125 MHz, 
DMSO-d6; Me4Si): δ = 161.92 (C-9), 156.68 (C-8), 155.47 (C-6), 150.20 (C-5), 147.32 (C-1), 
134.39 (C-3), 133.28 (C-2), 123.69 (C-4), 14.03 (C-7) ppm. IR (KBr; ν/cm-1):  =: 3392m, 
3268s, 3059vs, 2931m, 2651m, 2118w, 1725w, 1692vs, 1605s, 1511m, 1366s, 1175m, 974w, 
816m, 646w 
 
2.4. Synthesis of ethyl (2E)-2-[1-(pyridin-3-yl)ethylidene]hydrazinecarboxylate hydrochloride 
hydrate (HL3, C10H16ClN3O3) 
 
To a solution of ethyl carbazate (104 mg, 1 mmol) in water (25 cm-3) was added  
3-acetylpyridine (0.11 cm-3, 1 mmol) followed by a few drops of conc. HCl and the mixture 
was refluxed for 3 h. After 10 days colorless crystals were formed (200 mg, 76%), m.p.: 215 
ºC. Anal. Calc. for C10H16ClN3O3: C, 45.89; H, 6.16; N, 16.06. Found: C, 45.73; H, 6.16; N, 
15.87 %. 1H NMR (500 MHz; DMSO-d6; Me4Si): δ = 10.59 (s, 1 H, N(3)H), 9.05 (d, 1 H, 4J 
= 2.0, H-1), 8.87 (dd, 1 H, 3J = 5.6, 4J = 1.0, H-5), 8.77 (m, 1 H, 3J = 8.5, 4J = 1.5, H-3), 8.04 
(dd, 1 H, 3J = 6.0, 5J = 2.0, H-4), 4.18 (q, 2 H, 3J = 7.0 C(9)H2), 2.30 (s, 3 H, C(7)H3), 1.24 (s, 
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3 H, C(10)H3) ppm. 13C NMR (125 MHz, DMSO-d6; Me4Si): δ = 153.99 (C-8), 143.74 (C-6), 
141.52 (C-5), 141.41 (C-1), 139.42 (C-3), 137.15 (C-2), 126.79 (C-4), 61.02 (C-9), 14.55 (C-
7), 13.64 (C-10) ppm. IR (KBr; ν/cm-1):  =: 3407s, 3361s, 2997vs, 2361w, 2026w, 1738vs, 
1644m, 1550m, 1530s, 1462s, 1395m, 1229vs, 1041m, 890w, 727w. 
 
2.5. Synthesis of the complex [ZnCl2(HL1)2] (1, C16H20Cl2N8O2Zn) 
 
To a solution containing (2E)-2-[1-(pyridin-3-yl)ethylidene]hydrazinecarboxamide 
hydrochloride (HL1) (25 mg, 0.1 mmol) in methanol (15 cm-3) was added 
Zn(CH3COO)2·2H2O (21 mg, 0.1 mmol) dissolved in 5 cm-3 of methanol. The mixture was 
refluxed for 4 h forming a colorless solution. After ten days white crystals suitable for X-ray 
diffraction were formed (18 mg, 73 %), m.p.: 240 ºC. Anal. Calc. for C16H20Cl2N8O2Zn: C, 
39.01; H, 4.09; N, 22.74. Found: C, 38.91; H, 4.15; N, 22.44 %. 1H NMR (500 MHz; DMSO-
d6; Me4Si): δ = 9.17 (s, 2 H, N(3)H), 8.96 (s, 2 H, H-1), 8.55 (d, 2 H, 3J = 7.5, H-5), 8.08 (d, 2 
H, 3J = 7.8, H-3), 7.36 (dd, 2 H, 1J = 7.8, 3J = 5.0, H-4), 6.25 (s, 4 H, N(4)H2), 2.27 (s, 6 H, 
C(7)H3) ppm. 13C NMR (125 MHz, DMSO-d6; Me4Si): δ = 157.29 (C-8), 148.84 (C-5), 
146.91 (C-1), 141.63 (C-6), 134.09 (C-3), 133.67 (C-2), 123.70 (C-4), 13.10 (C-7) ppm. IR 
(KBr; ν/cm-1):  =: 3430m, 3196m, 1697s, 1630w, 1466m, 1314w, 1098m, 1058m, 824w, 
768w, 695w, 537w. 
 
2.6. Crystal structure determination 
 
Crystal data and refinement parameters of compounds HL1, HL3 and 1 are listed in 
Table S1. The X-ray intensity data were collected at room temperature with a Nonius Kappa 
CCD diffractometer equipped with graphite-monochromated Mo Kα radiation  
(λ = 0.71073 Å) for HL1 and 1 and with an Agilent SuperNova dual source with an Atlas 
detector equipped with mirror-monochromated Mo Kα radiation (λ = 0.71073 Å). The data 
were processed by using DENZO [16] or CrysAlis PRO [17]. The structures were solved by 
direct methods (SHELXS-97 [18] for HL1 and 1 and SIR-92 [19] for HL3) and refined by a 
full-matrix least-squares procedure based on F2 using SHELXL-97 [18]. All non-hydrogen 
atoms were refined anisotropically. All hydrogen atoms bonded to carbon were included in 
the model at geometrically calculated positions and refined using a riding model. The  
N-bound hydrogen atoms were located in a difference map and refined with the distance 
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restraints (DFIX) with N-H = 0.86 and with Uiso(H) = 1.2Ueq(N). The water hydrogen atoms 
in HL1 and HL3 were located in a difference map and refined using distance restraints 
(DFIX) with O–H = 0.96 and with Uiso(H) = 1.2Ueq(O). 
 
2.7. Microorganisms 
 
The antimicrobial activity was evaluated using seven different laboratory control strains 
of bacteria, i.e., the Gram-positive: Staphylococcus aureus (ATCC 25923), Staphylococcus 
epidermidis (ATCC 12228), Kocuria rhizophila (ATCC 9341), Bacillus subtilis (ATCC 6633) 
and the Gram-negative: Escherichia coli (ATCC 25922), Klebsiella pneumoniae (ATCC 
13883), Pseudomonas aeruginosa (ATCC 27853), and two strains of yeast, i.e., Candida 
albicans (ATCC 10259 and ATCC 10231). Overnight broth cultures of each strain were 
prepared, and the final concentration in each well was adjusted to 2 x 106 CFU mL-1 for the 
bacteria and 2 x 105 CFU mL-1 for the yeast. The investigated compounds were dissolved in 
1% dimethyl sulfoxide (DMSO) and then diluted to the highest concentration. Two-fold serial 
concentrations of the compounds were prepared in a 96-well microtiter plate over the 
concentration range 31.25–500 µg mL-1. The microbial growth was determined after 24 h 
incubation at 37 ºC for the bacteria and after 48 h incubation at 26 ºC for the fungi. The MIC 
is defined as the lowest concentration of the compound at which no visible growth of 
microorganism is observed. 
 
2.8. Brine shrimp assay 
 
A teaspoon of lyophilized eggs of the brine shrimp Artemia salina was added to 1 L of 
the artificial sea water containing several drops of yeast suspension (3 mg of dry yeast in 5 
mL distilled water), and air was passed through the suspension thermostated at 28 ºC, under 
illumination for 24 h. The tested substances were dissolved in DMSO. In a glass vial, into 1 
mL of artificial sea water 1–2 drops of yeast extract solution (3 mg in 5 mL of distilled water) 
and 10–20 hatched nauplii were added, and finally solutions of all derivatives to the 
appropriate concentrations. For each concentration, two determinations were performed. The 
vials were left at 28 ºC under illumination for 24 h, and afterwards live and dead nauplii were 
counted. LC50 was defined as the concentration of a drug that causes death of 50% nauplii. 
DMSO was inactive under applied conditions. 
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2.9. Cells and treatment 
 
Human promyelocytic leukemia (HL-60), human glioma (U251), rat glioma (C6), mouse 
fibrosarcoma (L929) and mouse melanoma (B16) cell lines were obtained from the European 
Collection of Animal Cell Cultures (Salisbury, UK). The cells were cultured at 37 °C in a 
humidified atmosphere with 5% CO2, in a HEPES (20 mM)-buffered RPMI 1640 cell culture 
medium supplemented with 2 mM L-glutamine, antibiotic/antimycotic mixture (1%) and 5% 
of fetal bovine serum (FBS) (all from PAA, Pasching, Austria). For the cell viability 
assessment, the cells were incubated in 96-well flat-bottom plates (2 × 104 cells/well). For the 
flow cytometric analysis, the cells were incubated in 24-well plates (2 × 105 cells/well). Cells 
were rested for 24 h and then treated with the complex, its corresponding ligand or cisplatin. 
Stock solutions of ligand and complex were made in water, and of cisplatin in DMSO. In 
experiments with cisplatin, both the untreated control cells and an additional control cell 
culture containing the appropriate amount of DMSO (always less than 0.5%) were 
investigated and no significant difference was observed (data not shown).  
 
2.10. Cell number determination 
 
The acid phosphatase assay was used to measure cell numbers as previously described 
[20]. The assay is based on the hydrolysis of the p-nitrophenyl phosphate by intracellular acid 
phosphatases in viable cells to produce p-nitrophenol. In brief, p-nitrophenyl phosphate 
solution (10 mM p-nitrophenyl phosphate in 0.1 M sodium acetate buffer, pH 5.5, with 0.1% 
Triton X-100) was added to each well and the samples were incubated for 2 hours. Reaction 
was stopped by addition of NaOH (1 M) and the absorbance, which is directly proportional to 
the cell number, was measured in an automated microplate reader at 405 nm (Sunrise, 
TECAN, UK). The results were presented as % absorbance relative to untreated control 
cultures. The IC50 values were calculated using GraphPad Prism (GraphPad Software Inc.). 
 
2.11. Flow cytometric analysis of apoptotic parameters, ROS production and acidic vesicle 
detection 
 
Flow cytometry analysis was performed on a FACSCalibur flow cytometer (BD 
Biosciences, Heidelberg, Germany), using CellQuest Pro software for acquisition and 
analysis. Cell cycle parameters were assessed by flow cytometric analysis of ethanol-fixed 
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cells stained with DNA-binding dye propidium iodide (PI) as previously described [20]. The 
results are presented as a percentage (%) of cells in different phases of cell cycle (G0/G1, S, 
G2/M), and in sub-G0 compartment (hypodiploid cells), that were considered apoptotic. 
Intracellular production of reactive oxygen species was determined by measuring the intensity 
of green fluorescence (FL1) emitted by the redox-sensitive dye dihydrorhodamine 123 (DHR; 
Sigma-Aldrich, St. Louis, MO), which was added to cell cultures  
(1 µM) at the beginning of treatment. The content of acidic vesicles (i.e. lysosomes, 
autolysosomes) was quantified by flow cytometry following supravital acridine orange 
staining. After incubation, cells were washed with PBS and stained with acridine orange (1 
µM; Sigma, St. Louis, MO) for 15 min at 37 oC. Accumulation of acidic vesicles was 
quantified as red/green fluorescence ratio (mean FL3/FL1), and the results presented as 
representative histograms with mean ± SD values from three separate experiments. 
 
2.12. Computational details 
 
All of the density functional calculations were carried out with the Amsterdam Density 
Functional (ADF, version 2012.01) [21,22] program. Uncontracted basis sets of Slater-type 
orbitals (STOs) of triple-ζ quality plus polarization functions (TZP, using the frozen-core 
approach [22]) and even-tempered basis sets of quadruple-ζ quality (ET-pVQZ) [23] were 
used. The geometries were obtained at the PBE-D/TZP [24,25] level, and energies and NMR 
chemical shifts were obtained at SSB-D/ET-pVQZ [26]. Both functionals include Grimme’s 
dispersion (D2) corrections [25]. All calculations included a dielectric continuum solvation 
model (COSMO [27–29]), with parameters appropriate for water (geometries) or DMSO 
(NMR). The geometry optimizations were carried out with the QUILD program [30] that uses 
superior optimization routines based on adapted delocalized coordinates [31]. The NMR 
chemical shifts were referenced against tetramethylsilane (TMS). The SSB-D functional was 
recently found to be one of the best density functionals for obtaining computed NMR 
chemical shifts [32]. 
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3. Results and discussion 
 
3.1. General 
 
The condensation reaction of 3-acetylpyridine and semicarbazide, oxamic hydrazide and 
ethyl carbazate in water was performed similary to the procedure by Wyrzykiewicz and 
Blaszczyk [33], affording three ligands: HL1, HL2 and HL3 (Scheme 1), respectively. Using 
these ligands and Zn(OAc)2·2H2O in molar ratio 2:1 in methanol solution only in the case of 
HL1 a defined product could be isolated. Zn(II) complex with the formula [ZnCl2(HL1)2] (1) 
was obtained with two ligands HL1 coordinated in a monodentate fashion (Scheme 1). 
 
Scheme 1. 
 
3.2. Description of the crystal structures 
 
To confirm the coordination of HL1 to Zn cation single-crystal X-ray analysis was 
undertaken. The molecular structure of complex 1 is shown in Fig. 1. Crystal structures and 
hydrogen-bonding representation of compounds HL1 and HL3 are illustrated in  
Figures S1–S4 in the Supplementary material. Crystal data, structure refinement defects and 
the selected bond distances and bond angles of HL1, HL3 and 1 are listed in Tables S1 and 
S2. Hydrogen bonding geometry of compounds HL1, HL3 and 1 are given in Table S3. 
Compound 1 cystallizes in orthorhombic crystal system (space group Pbcn) where the Zn(II) 
ions are lying on a two-fold rotation axes. The geometry around the metal centre is 
tetrahedral. The two HL1 ligands are monodentately coordinated through the pyridine N1 
atom with Zn–N1 distance of 2.055(2) Å. The Zn–Cl bond distance in complex 1 is 2.2298(6) 
Å. The average of the Zn containing angles is 110.7º and this is very close to ideal tetrahedron 
angle. In the compound 1 there are two N–H···O hydrogen bonding interactions including 
hydrazine N3 and amide N4 atom as a donor and carbonyl oxygen O1 as an acceptor. These 
interactions lead to the formation of 2D puckered layer in the crystal structure (Fig. 2). 
 
Fig. 1. 
 
Fig. 2. 
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3.3. NMR studies 
 
Comparison of 1H NMR spectra of the complex 1 with those of HL1 ligand gave 
additional support for the structure. It was observed that all protons of the free ligand were 
observed in the spectrum of the complex, suggesting that no deprotonation occurred. In the 
spectrum of the complex large upfield shifts of pyridine ring atoms were observed upon 
complexation, suggesting that coordination occurred via pyridine nitrogen.  
Further confirmation was established by comparing the 13C NMR spectrum of the free 
ligand with that of the complex, indicating that the ligand was coordinated as a monodentate, 
since there were large changes in chemical shifts of pyridine ring carbons, and small changes 
of side chain carbon signals. 
Complexes with ligands HL2 and HL3 could not be isolated. Therefore, NMR spectra in 
DMSO-d6 solution of mixtures of Zn(CH3COO)2·2H2O and either HL1, HL2 or HL3 (mole 
ratio metal : ligand = 1 : 2) were recorded. the ligands differed in their behaviour. In case of 
HL1 only sharp signals of the complex were detected. In case of HL3 two sets of signals for 
all the pyridine hydrogens were observed, with approximate ratio free ligand : bound ligand = 
3 : 2. In case of HL2 signals of the ligand were shifted and broadened, indicating an 
equilibrium between free and complexed ligand. No changes in signal positions for the 
surroundings oh the other possible donor atoms were observed, so that in all cases only 
pyridine nitrogen was coordinated. 
 
3.4. Computational studies 
 
The structure of 1 was corroborated by a computational study at the PBE-D/TZP level 
[24,25], including solvent effects through a dielectric continuum model (COSMO) [27–29]. 
Two structures were obtained with an energy difference (at SSB-D [26] / ET-pVQZ [23]) of 
ca. 0.3 kcal·mol-1. The only difference between them is the rotation of the HL1 ligands as a 
whole as shown in Fig. 3. As can be seen from this figure, it hardly has an effect on the Zn–
ligand distances. The computed distances are very close to the X-ray distances (Zn–N 2.07 Å, 
Zn–Cl 2.27 Å). 
Fig. 3. 
 
We also computed the NMR data at the SSB-D/ET-pVQZ level, which has recently  
been [32] found to be one of the best methods to predict 1H and 13C chemical shifts. The 
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computed shifts agree well with the experimental spectra (see Supplementary material, Table 
S4), and support the formation of compound 1. The formation of 1 with two HL1 ligands in 
monodentate coordination, and not the formation of a compound with only HL1 ligand in a 
bidentate coordination, is further corroborated by the computed reaction energies (at SSB-
D/ET-pVQZ): 
1·HL1 + ZnCl2 → ZnCl2(HL1)1 ∆E = –28.4 kcal·mol-1 
2·HL1 + ZnCl2 → ZnCl2(HL1)2 (1) ∆E = –43.8 kcal·mol-1 
Futhermore, binding energies for the formation a complex with HL2 ligand  
(–40.2 kcal/mol) and HL3 ligand (–40.9 kcal/mol) at the same level of theory, indicate that 
the other two zinc complexes are also possible and would have similar structures but up to 
now we were unable to isolate them. The experimental NMR evidence shows that complexes 
with HL2 and HL3 are less stable which is in accordance with calculated binding energies. 
 
3.5. Antimicrobial activity  
 
The complex 1 exhibited moderate antimicrobial activity. All tested strains of 
microorganisms were sensitive. The best inhibitory effect was detected against 
Staphylococcus epidermidis, Kocuria rhizophila, Bacillus subtilis and Pseudomonas 
aeruginosa (MIC values 62.5 µg /ml). Inhibitory activity against all other tested bacteria was 
significantly lower (MIC values >100 µg/mL). Interestingly, one strain of yeast Candida 
albicans (ATCC 10259), was more sensitive than the other one (Table 1). The ligand HL1 as 
well as compounds HL2, HL3 and zinc acetate were inactive.  
 
Table 1 
Antimicrobial activity.  
 
Microorganism  
HL1 
(µg/mL) 
(MIC) 
HL2 
(µg/mL) 
(MIC) 
HL3 
(µg/mL) 
(MIC) 
1 
(µg/mL) 
MIC 
Zn(OAc)2·2H2O 
(µg/mL) 
MIC 
Staphylococcus aureus 
ATCC 25923 
>500 >500 250.0 125.0 >500 
Staphylococcus 
epidermidis 
ATCC 12228 
>500 >500 500.0 62.5 500 
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Kocuria rhizophila 
ATCC 9341 
>500 >500 500.0 62.5 250 
Bacillus subtilis 
ATCC 6633 
>500 >500 500.0 62.5 500 
Escherichia coli 
ATCC 25922 
>500 >500 >500 125.0 >500 
Klebsiella pneumoniae 
ATCC 13883 
>500 >500 >500 125.0 >500 
Pseudomonas aeruginosa  
ATCC 27853 
>500 >500 >500 62.5 >500 
Candida albicans 
ATCC 10259 
>500 >500 500 62.5 500 
Candida albicans 
ATCC 10231 
>500 >500 500 125.0 500 
 
 
3.5. Brine shrimp test 
 
In the brine shrimp test which can be correlated to cell-line toxicity and antitumor  
activity [34,35] 1 showed a moderate activity (Table 2), the ligand being less active. In this 
test compounds HL2 and HL3 showed a weak to moderate activity. 
 
Table 2 
Toxic effect (expressed as LC50 values in µM) of the investigated compounds on  
Artemia salina. 
Compound LC50 (µM) 
HL1 0.395 
HL2 0.371 
HL3 0.684 
1 0.205 
Zn(OAc)2·2H2O 0.674 
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3.6. Antitumor activity 
 
The acid phosphatase assay demonstrated that the investigated complex reduced the cell 
numbers in cultures of the five tested cancer cell lines in a dose-dependent manner, while the 
ligand was inactive (Table 3.). 
 
Table 3 
The cytotoxicity of ligand and complex in various cancer cell lines and comparison with 
cisplatin. 
 IC50 (µM)  
compound B16 C6 L929 HL-60 U251 
cisplatin 42.15 ± 1.52 12.9 ± 4.8 11.2 ± 3.4 1.50 ±0.09 14.5 ± 3.3  
HL1 >100 >100 >100 >100 >100 
1 91.01 ± 3.58 92.96 ± 5.21 41.70 ± 3.62 63.54 ± 5.14 80.91 ± 4.72 
 
We next assessed if overproduction of reactive oxygen species (ROS) could be 
responsible for the observed cytotoxic effects of 1. Complex 1 strongly induced the formation 
of ROS in both HL-60 and L929 cell lines, reaching the peak after 6 hours of incubation, as 
measured by DHR fluorescence (Fig. 4a–c). However, this was not accompanied by rise in 
superoxide (O2-) production, since, after the same incubation times, no increase in superoxide-
derived dihydroethidium (DHE) fluorescence was observed (data not shown). It may therefore 
be assumed that the observed increase in ROS production cannot be attributed to the 
superoxide overproduction induced by 1, but rather to decrease in the antioxidative capacity 
of the cells. Contrary to 1, ligand HL1 showed no activity. 
The role of ROS in cytotoxic effect of 1 was further confirmed by pretreatment with ROS 
scavenger, N-acetylcysteine (NAC). NAC pretreatment partially abolished the cytotoxic 
action of 1. (Fig. 4d). These data indicate that the antitumor effect of 1 at least in part depends 
on ROS. 
Fig. 4. 
 
In order to further explore the observed antitumor effects of 1, its ability to influence the 
cell cycle progression was tested. The propidium iodide-based analysis of the DNA content in 
HL-60 leukemic (Fig. 5a and c) and L929 fibrosarcoma cells (Fig. 5b and d) revealed that 
complex 1 at the concentration of 100 µM (48 h) induced DNA fragmentation in both cell 
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lines (17.34% and 20.55% of cells in sub G0 phase, respectively), together with decrease in 
proliferation rate, indicated by the reduced percentage of cells in S and G2/M phase. The 
slowing down in the DNA replication was especially pronounced in HL-60 cell line, where 
percentage of cell in S phase decreased from 33.95% (Fig. 5a), to 21.38% (Fig. 5c). 
 
Fig. 5. 
 
It has been shown that high level of ROS can induce autophagy, a catabolic process 
involving the degradation of the cell's own components and damaged molecules in 
autolysosomes [36]. The ability of 1 to induce autophagy in the HL-60 leukemia (Fig. 6a and 
c) and L929 mouse fibrosarcoma cell line (Fig. 6b and d) was next assessed. Flow cytometry 
analysis of acridine orange-stained cells demonstrated a clear increase in red/green (FL3/FL1) 
fluorescence ratio in both HL-60 (Fig. 6c) and L929 cells (Fig. 6d) exposed to 1 (100 µM, 
24h), compared to the untreated, control cells (Fig. 6a and b). This indicated that treatment 
with 1 caused intracellular accumulation of acidic organelles (lysosomes/autolysosomes), that 
is consistent with autophagy induction. In order to establish the role of autophagy in the 
observed cytotoxic effect of 1, i.e. if observed autophagy induction contributes to cell death, 
or has a protective role, cell viability of L929 cells was measured in the presence of potent 
proton pump inhibitor bafilomycin A1, that impairs lysosomal acidification. Bafilomycin 
treatment, in concentration that alone did not affect cell viability (100 nM) caused further 
decrease in cell viability (from 42.9% to 30.2%), indicating that autophagy induction may, at 
least in part, help diminish the cytotoxic effect of 1 on L929 cell line. 
 
Fig. 6. 
 
4. Conclusion 
 
A Zn(II) complex of the Schiff base of 3-acetylpyridine and semicarbazide, where two 
ligands were monodentately coordinated, was obtained. This behaviour is a consequence of a 
much higher stability of the structure of the complex with two ligands bound as monodentates 
than the hypothetical structure with one ligand bound as a bidentate, as calculated at SSB-
D/ET-pVQZ level of theory. 
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Complex 1 showed moderate antibacterial, antifungal and cytotoxic activities. It is likely 
that the biological activity is a consequence of overproduction of ROS. The complex 1 
induced autophagy in tumor cell lines, which is a protective effect from cytotoxic action of 1. 
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Abbreviations  
 
HL1 (2E)-2-[1-(pyridin-3-yl)ethylidene]hydrazinecarboxamide hydrochloride 
dihydrate  
HL2  2’-[1-(3-pyridinyl)ethylidene]oxamohydrazide 
HL3  (2E)-2-[1-(pyridin-3-yl)ethylidene]hydrazinecarboxylate hydrochloride hydrate 
TMS  tetramethylsilane 
COSY  correlation spectroscop 
HSQC  Heteronuclear Single Quantum Coherence 
HMBC Heteronuclear Multiple Bond Correlation 
HL-60  Human promyelocytic leukemia 
U251  human glioma  
C6  rat glioma 
L929  mouse fibrosarcoma 
B16  mouse melanoma 
PI  propidium iodide 
ROS   reactive oxygen species 
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Appendix A. Supplementary data 
 
Crystallographic data for the ligands HL1 and HL3 and the complex [ZnCl2(HL1)2] may be 
obtained from the Cambridge Crystallographic Data Centre (CCDC, 12 Union Road, 
Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; e-mail: deposit@ccdc.cam.ac.uk or 
www: http://www.ccdc.cam.ac.uk) on quoting the depository numbers CCDC 901497, 
901498 and 901499, respectively.  
Supplementary data to this article can be found online at doi... 
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Figure captions: 
 
Fig. 1. Molecular structure of 1, showing the atom-numbering scheme. 
 
Fig. 2. Hydrogen-bonding network of compound 1. 
 
Fig. 3. Two conformations of 1, related to each other by a rotation of the HL1 ligands as a 
whole. The compound in red is almost identical to the X-ray structure (see Fig. 1). 
 
Fig. 4. Induction of oxidative stress by 1. (a) HL-60 and (b) L929 cells were incubated with 1 
for 6 hours, stained with dihydrorhodamine 123 and analyzed by flow cytometry. (c) Time-
dependence of the increase in ROS production. (d) The cell viability of L929 cells following 
the treatment with 1 (100 µM) for 48 hours, in conditions of pretreatment (1 hour) with ROS 
scavanger, N-acetylcysteine (NAC) assessed by acid phosphatase assay. Flow cytometry 
histograms of DHR-stained L929 and HL-60 cells from the representative of 3 separate 
experiments are presented. (*p < 0.05). 
 
Fig. 5. The effects of 1 on cell cycle and apoptosis of tumor cells. L929 and HL-60 cells were 
cultivated for 48 h in the absence or presence of 100 µM 1, stained with propidium iodide (PI) 
following fixation in ethanol. DNA content/cell cycle analysis was performed by flow 
cytometry in the control (HL-60, a; L929, b) and treated cells (HL-60, c; L929, d). The 
histograms from the representative experiment are presented, while cell cycle distribution 
values are means from three independent experiments. 
 
Fig. 6. Induction of autophagy by 1. L929 and HL-60 cells were cultivated for 24h in the 
absence or presence of 100 µM 1, stained with acridine-orange and autophagy induction was 
examined by flow cytometry. The treatment caused increase in red/green (FL3/FL1) 
fluorescence ratio in both (c) HL-60 and (d) L929 cells exposed to 1 (100 µM, 24h), 
compared to the respective control cells (a and b). The results are presented as representative 
histograms and FL3/FL1 ratio presented as mean±SD from three independent experiments. 
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Scheme Caption: 
 
Scheme 1. Synthesis of the ligands HL1, HL2, HL3 (a) and the formation of complex 
[ZnCl2(HL1)2] (1) (b). 
  
23 
 
 
Fig. 1. 
  
24 
 
 
Fig. 2. 
  
25 
 
 
Fig. 3. 
  
26 
 
 
Fig. 4. 
  
27 
 
 
Fig. 5. 
  
28 
 
 
Fig. 6. 
  
29 
 
 
 
Scheme 1. 
  
30 
 
 
 
  
31 
 
 
 
• Tetrahedral complex of Zn(II) with 3-acetylpyridine semicarbazone 
• DFT calculations on stabilities of various structures 
• Moderate antibacterial, antifungal and cytotoxic activities 
• Induction of ROS in tumor cell lines by a complex with a non-redox active metal 
• Effect on cell cycle progresion in tumor cell lines and induction of autophagy 
 
